Downregulation of LGR4 decreases ARPE-19 cell migration. by Qiang Hou (495704)

AQP5 expression is decreased in lung of mice exposed to hypoxia. by Jitesh D. Kawedia (384551)

Decreased expression of ATG5 upon the siRNA transfection. by Manisha Naskar (2613763)

Changes in V_T and FRC during decreasing PEEP. by Marcus J. Kitchen (444759)

“…<p>The increase in tidal volume (V_T) and decrease in functional residual capacity (FRC) when positive end-expiratory pressure (PEEP) is decreased in 5 cmH₂O stepwise decrements (10-5-0PEEP), large steps (10-0PEEP) and from a small step (5-0PEEP) in the ventilated lung. …”

TGF-β-mediated EMT decreases Dlg5 expression. by Takuhito Sezaki (169150)

“…TGF-β treatment induced EMT and decreased Dlg5 expression. The results are representative of at least three independent experiments.…”

5-AZA decreases DNA methylation levels in neonatal hearts. by Maresha S. Gay (693467)

Trial profile. by Chanel Avenant (409756)

“…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”

Transfer of RSV-infected <i>Kdm5b</i>-deficient DCs leads to a decreased pathogenic pulmonary RSV challenge. by Catherine Ptaschinski (756139)

Weight related parameters of subjects carrying (heterozygote) <i>NR5A1</i> mutations. by Jana Malikova (615672)

Subjects:

Promoter reporter studies for reported <i>NR5A1</i> mutations by Jana Malikova (615672)

Subjects:

Promoter reporter studies for SF-1 regulating the human <i>BDNF</i> promoter I and comparative studies of specific <i>NR5A1</i> mutations on <i>BDNF</i> promoter activity. by Jana Malikova (615672)

Subjects:

Dephosphorylation of AMPK by PP2A phosphatase promotes neuritogenic effect of SIM in SH-SY5Y cells. by Varshiesh Raina (457377)

“…Simultaneously, inhibition of PP2A activity by Fostriecin showed increase in pAMPK (Thr-172) levels in presence or absence of SIM at 6 hrs <b>E</b>) Morphology of SH-SY5Y cells at 10 X magnification under light microscope showing significant (<i>p</i> < 0.001) decline in neuritogenic effect of SIM in presence of Fostriecin and an AMP analogue i.e. …”

Fig 2 - by Muhammad Imran Nisar (10226212)

Subjects:

Individual serotype carriage rates over the study period. by Muhammad Imran Nisar (10226212)

Subjects:

The carriage rate of VT serotypes by number of doses of vaccine. by Muhammad Imran Nisar (10226212)

Subjects:

Serotype specific carriage rate from 2014–18 in Matiari, Pakistan. by Muhammad Imran Nisar (10226212)

Subjects:

Serotype-specific carriage rate by vaccination status. by Muhammad Imran Nisar (10226212)

Subjects:

Serum samples and 50% NAI values. Serum samples taken from CEIRS study. by Harrison Powell (9040128)

SPR-based analysis of the interaction of non-specific his-tagged proteins (<i>Pf</i>MSP1) with <i>Pf</i>HtrA2-PDZ as control set; the sensorgrams were obtained by flowing increasin... by Shweta Singh (409313)

Twenty-two identified and replicated loci and their overlap with associations to metabolic traits and clinical phenotypes. by Johannes Raffler (793347)

“…<p>^a SNP with the strongest association to targeted metabolic traits (“lead SNP”)</p><p>^b SNP with the strongest association to non-targeted metabolic traits</p><p>^c manually added to the list of most plausible candidate genes derived by evidence-based selection</p><p>^d additional candidates match to other non-targeted traits that also associate with the lead SNP</p><p>^e results from GWAS (<i>P</i> < 5.0×10⁻⁸)</p><p>^f mutations determined in clinical studies</p><p>For each locus, we selected all variants that displayed genome-wide significant association signals to metabolic traits in the SHIP-0 cohort. …”